Hadasit Bio (HDST) — Cash Flow-to-Debt Ratio
Hadasit Bio (HDST) has a Cash Flow-to-Debt Ratio of -0.33x as of June 2022, meaning its operating cash flow of ILA-360.50K could theoretically repay 0% of its total liabilities (ILA1.10 Million) in one year. Explore HDST long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hadasit Bio Cash Flow-to-Debt Ratio (2013–2022)
Historical debt coverage capacity for Hadasit Bio across 10 annual periods. Also explore Hadasit Bio (HDST) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hadasit Bio (2013–2022)
Year-by-year debt coverage analysis for Hadasit Bio. For market capitalisation and broader financial context, see Hadasit Bio (HDST) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -0.55x | ILA-2.12 Million | ILA3.88 Million | ▲ +81.2% |
| 2021 | -2.91x | ILA-2.10 Million | ILA722.00K | ▼ -213.7% |
| 2020 | -0.93x | ILA-3.96 Million | ILA4.27 Million | ▼ -14.1% |
| 2019 | -0.81x | ILA-3.18 Million | ILA3.91 Million | ▲ +94.9% |
| 2018 | -15.93x | ILA-16.46 Million | ILA1.03 Million | ▼ -608.0% |
| 2017 | -2.25x | ILA-17.57 Million | ILA7.81 Million | ▼ -20.1% |
| 2016 | -1.87x | ILA-14.68 Million | ILA7.84 Million | ▼ -17.4% |
| 2015 | -1.60x | ILA-13.26 Million | ILA8.31 Million | ▼ -34.3% |
| 2014 | -1.19x | ILA-12.24 Million | ILA10.31 Million | ▼ -1.0% |
| 2013 | -1.18x | ILA-11.61 Million | ILA9.87 Million | — |